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RESEARCH ARTICLE
Systematic Review of Research into the Psychological Aspects
of Prostate Cancer in Asia: What do we Know?
Suzanne Kathleen Chambers1,2,3,4,5, Melissa Karen Hyde1, David Fu-Keung Ip6,
Jeffrey Charles Dunn1,3,7, Robert Alexander Gardiner5,7,8
Abstract
Background: To review the peer reviewed literature on the psychological aspects of the prostate cancer
experience of men in Asia. Materials and Methods: Medline and PsycINFO, CINAHL, ProQuest, and Web of
Science (1999 – November Week 4, 2012) were searched. Inclusion criteria were: included men with prostate
cancer and/or their partners or caregivers who identify as Asian recruited in an Asian country; and assessed
health-related quality of life, psychological and social adjustment relating to prostate cancer and published in
English after 1st January 1999 and prior to 30th November, 2012. Study aims; design; quality; level of evidence,
and key results were assessed. Results: 43 articles met all inclusion criteria and were retained for initial review.
Of these most focussed on health-related QOL with only five evidence Level IV studies from Japan and Taiwan
including a specific psychological focus. Of these, one was a cross-sectional case control study; three were crosssectional descriptive quantitative designs; one was a cross-sectional descriptive qualitative study. From the data
available, a substantive sub group of men with prostate cancer (approximately one third) in these countries
experience clinically high psychological distress and decision regret. Conclusions: Research on the psychological
needs of men with the increasingly prevalent condition of prostate cancer in Asian countries is scant with only a
small number of low level evidence descriptive studies identified. Future research to underpin the development
and evaluation of effective and culturally relevant psychological and supportive care interventions for such men
is urgently needed.
Keywords: Prostate cancer - systematic review - psychological adjustment - quality of life - Asia
Asian Pacific J Cancer Prev, 14 (4), 2621-2626

Introduction
In Western countries, prostate cancer is highly
prevalent such that in Australia, the United States, and
the United Kingdom it is now the most common internal
male cancer (Baade et al., 2009). This high incidence and
prevalence has been attributed to the increasing uptake of
PSA testing and a western lifestyle (Baade et al., 2009).
The diagnosis of cancer brings with it a psychological
burden consistent with a major life stress, and this is the
case for prostate cancer as for other cancers (Zabora et
al., 2001). Accordingly, psycho-oncology researchers in
countries with a high prostate cancer prevalence have
over the past decade focussed their efforts in developing
a clear understanding of the psychological impact of
prostate cancer on men and their partners and finding
effective ways to improve psychological outcomes for
those affected (Chambers et al., 2011). Research to
date suggests that a substantial subgroup of men with

prostate cancer experience ongoing clinically significant
psychological distress after prostate cancer, although
study limitations include small and non-representative
samples; inconsistency in measurement; and few
longitudinal studies (Bloch et al., 2007). More recent
research has demonstrated that men’s psychological
responses to prostate cancer are highly heterogeneous,
with younger men (especially those with lower incomes
and less education) most at risk of poorer outcomes
(Chambers et al., 2012a); with psychological factors such
as masculine self-esteem (Chambers et al., 2012b) and
coping approaches (Roesch et al., 2005) also important. An
issue however that has yet to be considered is the extent
to which researchers have considered the psychosocial
implications of a prostate cancer diagnosis for men in
non-Western countries.
Specifically, as PSA testing increases in non-Western
countries, lifestyle becomes more influenced by Western
trends in diet and physical activity, and life expectancy
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Results
Search results
The process of identifying relevant articles for the
review is outlined in Figure 1. The combined Medline
and PsycINFO, CINAHL, ProQuest, and Web of Science
database searches and cited reference searches identified
122 citations. On examination of titles and abstracts, 43
articles that met all inclusion criteria and included Asian
participants recruited in an Asian context were retained for
Articles identified by OvidSP Medline & PsycINFO, CINAHL, ProQuest, Web of Science,
and cited reference searches
(N=122)

Articles excluded after examining titles and abstracts (n=79)
- Reviews, systematic reviews, or meta-analyses (n=3)
- No Psychological Adj, Social Adj, QOL, or HRQOL (n=11)
- Surgery/Treatment only focus (n=11)
- Pharmacologic/Drug Therapy only focus (n=26)
-Domain-specific QOL only focus (n=28)

Articles potentially relevant and retrieved for evaluation
(n=43)
Included Psychosocial articles
(n=5)
- Cross sectional case control
(n=1)
- Cross sectional descriptive
quantitative (n=3)
- Cross sectional descriptive
qualitative (n=1)

p

Medline and PsycINFO, CINAHL, ProQuest, and
Web of Science (1999 – November Week 4, 2012) were
searched and articles related to prostate cancer were
extracted. Cited reference and hand searches of retrieved
article references lists were also conducted. The following
keywords and subject headings were used: Cancer.mp,
neoplasm$.mp, metastasis.mp, malign$.mp, prostat$.mp,
psychosocial.mp, well-being.mp, coping.mp, anxiety.
mp, depression.mp, HRQoL.mp, survivor.mp, pain.mp,
fatigue.mp, Asia$.mp. China.mp, Chinese.mp, Hong
Kong.mp, India$.mp, Indonesia$.mp, Japan$.mp, Korea$.
mp, Phillipines.mp, Filipino.mp, Taiwan$.mp, Thai$.
mp. To enhance the literature search, these terms were
used in conjunction with searches aimed at identifying a
comprehensive breadth of cancer-based research related
to psychological adjustment. For instance, “exp quality
of life/”, “exp social adjustment” and “exp psychological
adjustment/” were also searched. Potentially relevant
articles were identified by examining the title and abstract
and then retrieved for more detailed evaluation against
the inclusion criteria by two reviewers. Both qualitative
and quantitative studies were included. Editorials, books,
dissertations, case reports, commentaries, systematic
reviews, reviews, and meta-analyses were excluded.
Studies were included if they met the following predetermined inclusion criteria: Were published in English
and included men with prostate cancer and/or their
partners or caregivers who identify as Asian (either at least
80% of participants are Asian and had/have prostate cancer
or were partners or caregivers of prostate cancer patients
or there was an Asian specific sub-group analysis) and
were recruited in an Asian context; and Described quality
of life, health-related quality of life, or psychological and
social adjustment of prostate cancer patients who identify
as Asian; OR Compared quality of life, health-related
quality of life, or psychological adjustment of prostate
cancer patients who identify as Asian against healthy
controls who identify as Asian or against non-Asian
prostate cancer populations OR Assessed health-related
quality of life, psychological and social adjustment
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Materials and Methods

relating to prostate cancer and included an outcome of
interest – physical health, mental health, health utility,
cancer specific distress; depression/anxiety severity,
disability, mobility, physical activity, social activity, and
health status. Research articles that focussed principally on
domain-specific quality of life (i.e., urinary, bowel, sexual
problems) in relation to evaluating treatment effects and
that did not include a specific psychological component
were excluded. Studies that focussed on health-related
quality of life were noted but did not undergo quality
assessment or full review.
The methodological quality of the included
psychological studies was assessed independently by
two reviewers (SC, MH) and differences resolved by
consensus with separate criteria for qualitative and
quantitative studies. The assessment of the quality of
qualitative studies was based on criteria held in the
literature to denote high quality (Elliott et al., 1999; Daly
et al., 2007; Chwalisz et al., 2008). Criteria included
whether: the sampling frame was described, justified, or
met; the framework for the study design, methodology and
orientation disclosed; interviewer bias was addressed; the
method of analysis was described; reliability and validity
checks were included; data were clearly presented. To
assess the quality of the design of included quantitative
cross-sectional studies, criteria from established tools
for cohort and case-control studies (NHMRC, 2000)
were adapted focussing on representativeness of the
study sample (participant selection), measures applied
(reliability and validity), attrition bias (participation rates)
and evidence of follow up.

p

increases, the incidence of prostate cancer in the
Asia-Pacific is also increasing (Baade et al., 2012). As
examples, in South Korea between 1999 and 2009 prostate
cancer incidence rose by 13% per year (the largest increase
in the Asia-Pacific) followed closely by Shanghai with
an annual increase of 12% between 1988 and 2002. In
all, 14% of prostate cancer diagnoses worldwide occur
in the Asia Pacific, most often in Japan (32%) and China
(28%). On the basis that prostate cancer is now emerging
as a cancer control priority area for Asia in the future, the
need to understand the impact of prostate cancer on the
lives of men and their partners from non-Western cultures
will become critical for health services planning.
Accordingly, we undertook a review of the
psychological aspects of the prostate cancer experience
of men in Asia to describe the level of research activity
in this area and key areas of focus and from this provide
recommendations for future research.

p
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HR Quality of life articles (n=38)
- Cross sectional descriptive
quantitative (n=7)
- Prospective descriptive
quantitative (n=19)
- Comparison of side effects of
medical treatments (n=12)

Figure 1. Final Process of Inclusion and Exclusion of
Studies for the Literature Review

Patients

N = 167 men admitted for biopsy of the
prostate gland to confirm the diagnosis of
prostate cancer between April 2001 and
March 2003. 86 were subsequently allocated
to the case group (presence of prostate
cancer) and 81 to the control group (absence
of prostate cancer)
Case mean age: 65.8 yrs
Control mean age: 64.1 yrs

340 men with localized prostate cancer
treated with radical prostatectomy (n = 253)
or external beam radiation therapy (n = 87).
RP patients mean age: 68.9 yrs
ERBT patients mean age: 75.7 yrs

100 men diagnosed with prostate cancer who
underwent radical prostatectomy between
2004 and 2010
Mean age: 66.63 yrs

105 men who underwent radical prostatectomy
were recruited approximately 1 month posttreatment and participated in the study
approximately 3 months after treatment.
Participants were initially selected for either
the ‘support group’ (n = 62 recruited between
December 2007 and April 2010; received
psychological support in addition to normal
care and follow up) or the ‘non-support group’
(n = 43 recruited between August 2002 and
November 2007; received normal care and
follow up only).
Mean age support group: 65.42 yrs.
Mean age non-support group: 68.19 yrs

Narrative interviews were conducted between
December 2007 and March 2009 with 42
women with breast cancer and 49 men with
prostate cancer (various stages).
Men age distribution: (50-59 yrs n = 5; 60-69
yrs n = 18; 70-79 yrs n = 21; 80 ≤ yrs n = 5)

Study

Kumano
2005
(Japan)

Namiki
2007
(Japan)

Lin
2011
(Taiwan)

Lin
2012
(Taiwan)

Sato
2012
(Japan)

31% regretted undergoing radical prostatectomy. Top two reasons for regret were sexual
dysfunction (33%) and urinary incontinence (9%).
Stepwise multiple regression showed that significant predictors of treatment decision
regret were not choosing to have an RP again, a lack of understanding of the treatment and
complications, sexual bother, younger age, and bowel bother.

Significant difference in understanding cancer treatment and complications between support
group (82.1% understood) and non-support group (17.9% understood).

Treatment
decision
regret

Perceived
uncertainty
about
illness

n/a

Demographics including age, marital status, education level, employment status.
Disease-related variables including type of radical prostatectomy, number of
months after RP, and satisfaction with treatment (lower scores = less satisfied).
Disease-specific HRQOL – urinary, bowel and sexual function and bother
(UCLA Prostate Cancer Index)
Treatment decision regret (modified Clark regret scale, 4-items, 5-point Likert
scale scored 0 ‘none of the time’ to 5 ‘all of the time’).

Perceived uncertainty about illness (Chinese version of the Mishel Uncertainty
Illness Scale – MUIS)
Background data sheet including age, marital status, education level,
employment status, number of months since the RP procedure, occurrence of
urinary incontinence, level of understanding of prostate cancer treatment and
complications.
Psychological support was delivered by a researcher in the hospital predischarge, a research assistant by phone, and in-clinic visits after RP (twice
during the first month and once after the first month). Psychological support
content included: (i) 1hr of education about prostate anatomy, the RP procedure,
and associated complications; (ii) strategies to overcome complications; (iii)
listening to patient’s life experiences after RP; and (iv) questions and answers.

Extracted information from unstructured and structured parts of the interview
related to prognostic disclosure including information received from medical
professionals, the impact of cancer on life plans, and fears or worries about
the future.

To compare levels
of uncertainty for
men who received
psychological
support compared
to those who did
not after radical
prostatectomy

Explored the topic
of disclosure of life
prognosis

Participants who reported receiving information about life prognosis unexpectedly were
shocked by their prognosis, regardless of terminal or early stage.
Others sought prognostic information elsewhere (e.g. websites).
Others who asked for life prognosis disclosure felt it helped prepare them for end of life
Others feared that hearing prognostic information would become a self-fulfilling prophecy.
Authors concluded that prognostic information should include not only survival estimates
but also treatment implications and ‘meaningful use of time’, and that this information
should be used to empower patients in their decision-making.

Participant’s uncertainty was lower in the psychological support group compared to the
non-support group, F = 197.25, p < .001.

Followed up on average 32 months (RP) and 29 months (ERBT) post-treatment.
No statistically significant differences in psychological distress based on type of treatment
or sexual bother or sexual function.
Younger (70 yrs or below) had higher depression scores than older (over 70 yrs) men.
‘Cases’ (scoring 11 ≤ on HADS-T = psychological distress) as compared to ‘non-cases’
had lower HRQOL overall, and men with higher psychological distress had greater urinary
and bowel bother and dysfunction and IPSS scores, than ‘non-cases’.
Logistic regression showed that greater post-treatment psychological distress was predicted
by greater urinary bother (OR: 3.039, 95% CI: 1.49-6.18) and bowel dysfunction (OR:
2.343, 95% CI: 1.26-4.33) and higher IPSS (OR: 3.29, 95% CI: 1.84-5.89) after controlling
for type of treatment, age, comorbidities, PSA, time since treatment and adjuvant therapy.

Psychological
distress
(anxiety
and
depression)

General HRQOL emotional and social functions (SF-36)
Urinary, bowel and sexual function and bother (UCLA Prostate Cancer Index)
Voiding symptoms (International Prostate Symptom Score – IPSS)
Depression and anxiety (Hospital Anxiety and Depression Scale – HADS).
HADS-Total Score 0-10 categorised as ‘non-cases’, and scores 11 ≤ were
categorised as ‘cases’.

Examine the
association between
psychological
distress (anxiety
and depression)
and health-related
quality of life.

Understand the
treatment decision
regret experienced
by patients
after a radical
prostatectomy
a nd the fa c to rs
associated with
regret

Family history of prostate cancer, PSA, patient prediction of cancer diagnosis, and Type 1
personality (marginally p = .018) significantly different between case and control groups.
After controlling for patient prediction of cancer diagnosis and PSA, the variables Type 1
personality (OR: 4.2, 95% CI 1.2-14.6) and family history of prostate cancer (presence) (OR:
10.8, 95% CI 1.1-101.9) predicted prostate cancer diagnosis in multiple logistic regression
analysis, 66.5% correctly classified, Wald χ2 =22.6 (df = 4, p = .0002).

Prostate
cancer
diagnosis

History sheet including demographics, PSA level, patient prediction of cancer
diagnosis (0-100 Visual Analogue Scale), and family history of prostate cancer
within 3rd degree relatives.
Food consumption (Food Frequency Questionnaire – FFQ)
Harmony seeking – Type 1 personality (The Japanese version of the Short
Interpersonal Reactions Inventory – SIRI33)
General personality (NEO-FFI)
Coping style (The Coping Inventory for Stressful Situations - CISS)
Psychological stress response (Profile of Mood States – POMS)

Investigate whether
harmony-seeking
personality is
related to the
occurrence of
prostate cancer

Key Results

Planned
outcomes

Variables and corresponding measures

Aim

Table 1. Summary of Psychosocial Articles on Prostate Cancer in Asia
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Figure 2. Trend in Number of Asian Psychosocial and
HRQOL Prostate Cancer Articles from 1999-2012
(n=43)
review. Of these articles 38 were from Japan; three from
China and two from Korea. Figure 2 shows the trend in
number of articles over time. Research in this area began to
emerge in 2003 with a clear increase in 2009 that has since
declined. In the final search step and in line with the focus
of this review on identifying psychological research with
men with prostate cancer in Asia, research articles that
included a general or health-related quality of life (HRQOL) aspect but did not include a clearly defined focus
on psychological outcomes were excluded (n=38; 7 crosssectional descriptive quantitative studies; 19 prospective
descriptive quantitative studies; and 12 medical treatment
intervention efficacy) leaving 5 psychosocial articles.
The excluded HR-QOL articles predominantly
described the interaction between domain specific such
as urinary and bowel symptoms and HR-QOL, rather
than psychological morbidity per se. However, those
studies that did report and discuss the mental wellbeing
component of QOL (n=13; assessing Japanese patients)
tended to report improved function over time for men
with localised or low risk prostate cancer (Namiki et
al., 2005; 2009; Sugimoto et al., 2008; Wakatsuki et al.,
2008) with more interruption to wellbeing when men
were receiving androgen deprivation therapy (Namiki
et al., 2005; Wakatsuki et al., 2008) or had biochemical
recurrence (Namiki et al., 2007).
Study characteristics and outcomes of included
psychological studies
Of the five psychological articles retained, one was
a cross-sectional case control study; three were crosssectional descriptive quantitative studies; one was a
cross-sectional descriptive qualitative study (Table 1).
All were Level IV evidence (Olver et al., 2012). For the
quantitative studies participation rates were acceptable to
very good (78-91%); validated and reliable measures were
used; however no follow up assessments were undertaken
and the samples were not drawn from population based
registries.
One cross sectional Japanese study investigated the
relationship between personality and prostate cancer by
assessing 217 men pre- biopsy and then comparing cases
with controls(Kumano et al., 2005). Two variables were
found to predict a prostate cancer diagnosis, a family
history of prostate cancer (OR=4.2, 1.2-14.6; p<.05) and
having a ‘harmony seeking’ personality (OR=10.8, 1.1101.9; p<.05). Namiki et al. (2007) assessed 340 Japanese
men who had been treated for localised prostate cancer
by radical prostatectomy or radiation therapy and found
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substantive subgroups with high psychological distress
with 15% of patients reaching caseness for anxiety
and 46% reaching caseness for depression. Men who
reached caseness for overall psychological distress (34%)
had poorer HR-QOL compared to those who were not
distressed.
Lin (2012) in a cross sectional study in Taiwan assessed
illness uncertainty in two cohorts: one in which the men
had received a radical prostatectomy (n=62) and received
treatment education and empathic listening from the
researcher and a second in which the men did not receive
this support (n=43). Men who had received support had
lower uncertainty however, as the study only included
one post-test assessment, it is not possible to draw firm
conclusions from these results. The same author assessed
treatment regret in 100 Taiwanese men who had undergone
radical prostatectomy and found 31% to report regret
about their treatment decision with bothersome adverse
sexual and bowel side effects, with not understanding the
treatment and its complications predicting greater regret
(Lin, 2011).
Finally, Sato et al. (2012) undertook a qualitative
narrative analysis of 42 Japanese breast and 49 prostate
cancer patient experiences of being told their cancer
prognosis and their preferences for how this should be
done. While some men sought prognostic information
and saw this as a means of maintaining control over
their lives, others found this information shocking. A
reason given for not wanting prognostic information was
to maintain hope; and there was evidence of people not
understanding this information when it was given. Study
quality was good: a convenience sample was used and
a sample size rationale was provided, as were a clear
qualitative framework and data analysis with objective
measurement and presentation. However, checks for data
credibility were not well described.

Discussion
To date there has been scant research on the
psychological needs of men with prostate cancer in
Asian countries. Specifically, only a small number of
low evidence descriptive studies were found with study
limitations evident with regards to sampling frames and
cross sectional designs. Hence, from work to date it is not
possible to draw clear conclusions about how prostate
cancer impacts the psychological health of Asian men with
prostate cancer and what factors lead to poorer outcomes,
and this has implications for both research and practice.
There are well described differences in how different
cultural groups present with regards to psychological
distress. For example, somatic symptoms of distress
may be more commonly reported in Chinese populations
compared to Western groups (Parker et al., 2001), and
Chinese approaches to coping that are influenced by
Eastern philosophy and cultural beliefs may be more
focussed on maintaining internal control and acceptance
(Cheng and Chio, 2010). With regards to beliefs about
cancer, in Japanese Americans, compared to Caucasians,
there is a greater association of cancer with death and
less optimism about the curability of cancer that, at least
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in part, reflects differing cultural meanings about cancer
(Long and Long, 1982; Gotay et al., 2004). Given such
cultural differences, the knowledge gap about predictors,
mediators and prevalence of negative psychological
outcomes for Asian men after a prostate cancer diagnosis
makes designing well targeted psychological support
interventions for this setting problematic. From this we
conclude that developing an evidence base on how men in
Asia react to and cope with a prostate cancer diagnosis, and
from this how to best provide support, must be considered
a research priority.
It is concerning that there does not appear to be a
consistent increase in the research effort since 2005, not
only for studies addressing the psychological morbidity
associated with prostate cancer in Asian men but also for
quality of life studies. As well, the research undertaken
appears concentrated in only a few countries, particularly
Japan. This is a concerning gap, especially given the
increasing prevalence of prostate cancer in China. We
suggest that this lack of research cannot be explained
only by a lower prevalence of prostate cancer compared
with other cancers and other countries. Historically,
there has been a gender bias in psychosocial cancer
survivorship studies with men less represented compared
to women, although men’s involvement in such research
internationally appears to have increased substantially
over the past fifteen years (Hoyt and Rubin, 2012). It
may be that as psycho-oncology research in Asia further
develops the same trend will occur in the decades to
come, however this may not happen without adequate
resourcing. The resources that are needed to undertake
well designed psychological research with Asian men
with prostate cancer include valid and reliable assessment
measures that are culturally relevant; researchers skilled
in psycho-oncology and QOL research; prioritising of this
research by health care funders and service providers; and
a willingness of men to participate. Efforts to stimulate and
support the development of this capacity seem warranted.
The research identified in this review does however
suggest that as many as one third of men with prostate
cancer in at least one Asian country (Japan) experience
clinically high psychological distress after prostate cancer
(Namiki et al., 2007). Estimates of distress in Western
populations vary (Bloch et al., 2007) and this may relate
at least in part to differences in sampling frames and
measurement approaches. In our previous research,
and by comparison, we have found approximately 10%
of Australian men with prostate cancer to experience
clinically levels of anxiety, depression and cancer-specific
distress (Chambers et al., 2013; Steginga et al., 2004);
other authors have suggested that men with prostate cancer
experience increased psychological distress in the first
twelve months after diagnosis with men with advanced
disease experiencing greatest distress (Couper et al.,
2006). Australian studies further suggest that between a
third and a half of men with prostate cancer experience
high levels of unmet needs for psychological help and
unmet information and support needs for sexuality
concerns (Steginga et al., 2001; Smith et al., 2007). Thus
there may be some comparability between the distress
experiences of patients from at least these two contexts,

although again more research is needed.
It is of note that one Taiwanese study found evidence
of decision regret and uncertainty after prostate cancer
treatment, a finding that has been observed elsewhere
(Steginga et al., 2004). Decision support for men with
prostate cancer has been a specific area of research focus
in Western countries for some time where men newly
diagnosed with prostate cancer will frequently be offered
a range of different prostate cancer treatment modalities
(e.g., radical or robotic surgery; external radiation
therapy; brachytherapy; adjuvant androgen ablation),
all with differing side effect profiles, from which they
much choose a ‘best fit’ treatment option that matches
their personal preferences and values (Chambers et al.,
2011; 2012; Steginga et al., 2008). This also presents as
a key area for potential focus for future research in Asian
patient populations.
In conclusion, the limited research to date suggests
that a diagnosis of and treatment for prostate cancer has a
substantive negative effect on the psychological wellbeing
of men in Asia, as it does in Western countries. There
is a body of knowledge already developed in Western
countries that lays a foundation from which new research
with an Asian focus could be developed, taking note of
lessons already learned and ensuring cultural relevance
to the populations concerned. The development of a
research capacity and focussed agenda that ultimately
can underpin the development of effective and culturally
relevant psychological and decision support interventions
for men with prostate cancer in Asia, and their partners
and families, is needed.
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